• About AMEND

    We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our ‘family’.

    The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on multiple endocrine neoplasia (MEN) syndromes types 1, 2, and 3, medullary thyroid cancer (MTC), and Phaeochromocytoma and Paraganglioma (PPGL) syndromes.

  • Who we are
  • Aims of AMEND
  • How we are governed
  • Who our sponsors are
  • Annual Reports & Accounts
  • Coronavirus (COVID-19) Information